MEDIFAST, Inc. (NY:MED)
26.69
-0 (-0%)
| MEDIFAST, Inc. (NY:MED) Delayed : |
| Previous Close |
$26.69 |
|
52 Week High |
$28.67 |
|
| Open |
$26.87 |
|
52 Week Low |
$3.35 |
| Day High |
$27.06 |
|
P/E |
40.44 |
| Day Low |
$26.19 |
|
EPS |
$0.66 |
| Volume |
584,380 |
|
|
|
| More MED Info:
Chart
SEC Filings
Profile
Historical
Options
|
-
Oct 29, 2009 07:00AM
Medifast Reports Record Third Quarter 2009 Financial Results
-
Oct 22, 2009 08:00AM
Medifast, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, October 29, 2009
-
Oct 16, 2009 08:00AM
Medifast, Inc. Named by Forbes as One of 'America's 200 Best Small Companies'
-
Oct 15, 2009 09:41AM
Medifast Weight Control Centers Open New Location in Austin, TX
-
Oct 13, 2009 04:00PM
Medifast, Inc. Announces Appointment of Three Additional Independent Board Members
View All Press Releases
StreetInsider Reports on MED by Category
Comments on recent MED articles
Comments on MED
No comments are currently available.
on Sep 11, 2009
at 02:01 PM Medifast Stock at $19 The TSFL Multi-Level marketing will not win the day on YOY growth rates Medifast sports with a 40 PE at $19 a share. Major dilution underway. Medifast stock is risky speculation.
Article: Stocklemon.com issue negative report on Medifast (MED)
on Jun 10, 2009
at 02:16 PM MED DownGrade Medifast (NYSE – MED) downgraded due to insider trades, poor Auditor transparency/conflicts and potential risk that their recent Revenue reporting may be revised down. .This is going to get much worse before it gets better –going down to $5.00 So the Chairman’s household sold a cool Million dollars worth of the stock in the last round – Each share sold under the knowledge of an investigation into MED and its revenue recognition categories. “Brad” has been out posting again, a disclosure and dissemination of inside information in violation of SEC rules prohibiting such “insider” communications. (Whole Foods CEO ring a bell?) Minkow is not going away and appears to have made real headway with the Auditor conflict – (Selling shares or not – owning a brokerage house is the real conflict) I am asking here – does anyone know of an auditor of publicly traded companies, who also owns a Brokerage company too? I can’t find one at all! MED’s miraculous revenue increase last Q, - was mandatory to get MED off the NYSE’s dreaded “Watch List”. This revenue recognition was masterminded by the Chairman and the conflicted Auditor – it may have to be revised…. (What is the NYSE’s internal control doing about this too?)
Article: Medifast (MED) Chairman's Wife Cashes In Over $1M In Stock